Definium Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -157,753 | -75,222 | -40,740 | -65,984 |
EBIT | -75,853 | -40,740 | -65,991 | |
Net Income | -158,986 | -77,098 | -50,436 | -67,265 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -52,778 | -42,631 | -41,891 | -29,567 |
Cash | 655,267 | 262,518 | 257,837 | 19,959 |
Basic Shares | 110,684 | 108,790 | 89,327 | 85,885 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -527 | -3,162 | ||
EBITDA | -178,311 | -105,869 | -92,570 | -52,121 |
EBIT | -106,396 | -95,732 | -55,301 | |
Net Income | -183,793 | -108,679 | -95,732 | -56,796 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -131,560 | -79,129 | -64,365 | -50,139 |
Cash | 257,837 | 273,741 | 99,704 | 142,142 |
Basic Shares | 89,327 | 704,611 | 39,157 | 30,857 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.44 |
2026-03-31 | -$0.71 |
2025-12-31 | -$0.45 |
2025-09-30 | -$0.78 |